IP Library › Granted Patent US 12,435,313
Granted Patent B2
US 12,435,313 · App. 17/855,379 · Granted Oct 7, 2025

Lineage reprogramming to induced cardiac progenitor cells (iCPC) by defined factors

Inventors: Timothy Joseph Kamp (Madison, WI); Pratik Arvind Lalit (Madison, WI)
Assignee: Wisconsin Alumni Research Foundation
C12N5/0657C12N5/0661C12N2501/06C12N2501/415C12N2501/60C12N2506/1307
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,435,313
App. No.
17/855,379
Granted
Oct 7, 2025
Kind
B2
Abstract

Animal cells, notably adult fibroblasts, are advantageously reprogrammed in direct lineage reprogramming methods using defined factors to produce proliferative and multipotent induced cardiac progenitor cells (iCPC). The iCPC thus produced can be differentiated under suitable differentiation conditions to cardiac lineage cells including cardiomyocytes, smooth muscle cells, and endothelial cells, as evidenced by expression of lineage specific markers. Sets of factors effective in combination to reprogram the fibroblasts can include a set that includes some or all of 5 factors (Mesp1, Baf60c, Nkx2.5, Gata4, Tbx5), a set that includes some or all of 11 factors (Mesp1, Mesp2, Gata4, Gata6, Baf60c, SRF, Isl1, Nkx2.5, Irx4, Tbx5, Tbx20), a set that includes some or all of 18 factors (T, Mesp1, Mesp2, Tbx5, Tbx20, Isl1, Gata4, Gata6, Irx4, Nkx2.5, Hand1, Hand2, Tbx20, Tbx18, Tip60, Baf60c, SRF, Hey2), and a set that includes some or all of 22 factors (T, Mesp1, Mesp2, Tbx5, Tbx20, Isl1, Gata4, Gata6, Irx4, Nkx2.5, Hand1, Hand2, Tbx20, Tbx18, Tip60, Baf60c, SRF, Hey2, Oct4, Klf4, Sox2, L-myc).

Claims (11)

1. An isolated induced cardiac progenitor cell (iCPC) comprising one or more copies of one or more episomal vectors encoding five reprogramming factors of Mesp1, Baf60c, Nkx2.5, Gata4, and Tbx5, wherein the isolated iCPC is capable of differentiating into cardiomyocytes, SM-MHC + smooth muscle cells, and CD31 + endothelial cells,

wherein the iCPC is capable of proliferating and remaining multipotent for at least 5 passages in a culture medium comprising an activator of canonical Wnt signaling and an activator of Jak/Stat signaling, and

wherein the iCPC is NKx2.5+, Gata4+, Irx4+, and Cxcr4+.

2. An in vitro cell culture, comprising:

an isolated induced cardiac progenitor cell (iCPC) according to claim 1 ; and

a cell culture medium comprising an activator of canonical Wnt signaling in an amount sufficient to maintain proliferation and multipotency of the iCPC for at least 5 passages.

3. The in vitro cell culture of claim 2 , wherein the activator of canonical Wnt signaling comprises one or more of 6-bromoindirubin-3′-oxime (BIO), CHIR 99021, CHIR 98014, BIO-acetoxime, LiCl, SB 216763, SB415286, AR A014418, 1-Azakenpaullone, and Bis-7-indolylmaleimide.

4. The in vitro cell culture of claim 2 , wherein the cell culture medium further comprises an activator of Jak/Stat signaling.

5. The in vitro cell culture of claim 4 , wherein the activator of Jak/Stat signaling comprises an interleukin (IL)-6-related cytokine.

6. The in vitro cell culture of claim 5 , wherein the interleukin (IL)-6-related cytokine is Leukemia Inhibitory Factor (LIF), IL-2, IL-6, IL-11, leptin, and/or ciliary neurotrophic factor (CNTF).

7. The in vitro cell culture of claim 5 , wherein the interleukin (IL)-6-related cytokine is LIF.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2022
From: LALIT, PRATIK; KAMP, TIMOTHY
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 060406/0801 →
Continuity (3)
Continuation 14542280 · Nov 14, 2014
Provisional Application 61904881 · Nov 15, 2013
Related Publication 20230038168A1 · Feb 9, 2023
References Cited (46)
US 5464758A · Gossen et al. · 1995 [cited by applicant]
US 8268620B2 · Thomson et al. · 2012 [cited by applicant]
US 8486701B2 · Schwartz et al. · 2013 [cited by applicant]
US 10106772B2 · Thomson et al. · 2018 [cited by applicant]
US 10563176B2 · Ahlfors · 2020 [cited by examiner]
US 20110223670A1 · Schwartz · 2011 [cited by examiner]
US 20130216503A1 · Srivastava et al. · 2013 [cited by applicant]
Ieda et al, Cell. 142(3): 375-386 (Year: 2010). [cited by examiner]
Qyang et al Cell Stem cell, 1, 165-179 (Year: 2007). [cited by examiner]
Foshay et al Stem Cells, 23,530-543) (Year: 2005). [cited by examiner]
Snyder Journal of Biol. Chem. 285, 23639-23646 (Year: 2010). [cited by examiner]
Abu-Issa (Annu Rev. Cell Dev Biol. 23, 45-68 (Year: 2007). [cited by examiner]
Wang et al BMC Biotechnology, 14:75, 1-11 (Year: 2014). [cited by examiner]
Vukusic et al Biomed Res. Int; 1-11 (Year: 2013). [cited by examiner]
Pagliari et al Frontiers in Physiology, 1-10 (Year: 2014). [cited by examiner]
Dixon Molecular Therapy, 19(9), 1695-1703 (Year: 2011). [cited by applicant]
Lalit et al. “Lineage reprogramming of fibroblasts into proliferative induced cardiac progenitor cells by defined actors,” Cell Stem Cell, 2016, 18, 354-367. [cited by applicant]
Kattman et al. “Multipotent Flk1 + cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages,” Developmental Cell, 2006, 11, 723-732. [cited by applicant]
Wamstad et al Cell, 151, 206-220 (Year: 2012). [cited by applicant]
Stadtfeld et al. A reprogrammable mouse strain from gene targeted embryonic stem cells, Net Methods. 2010, 7 (1):53-55. [cited by applicant]
Carey et al. A single-gene transgenic mouse strain for reprogramming adult somatic cells, Net Methods. 2010 7 (1):56-59. [cited by applicant]
Steinhauser et al Regeneration of the heart; EMBO Molecular Medicine, vol. 3, 701-712 (Year: 2011). [cited by applicant]
Kitajima et al., Development. 127:3215-3226 (Year: 2000). [cited by applicant]
Cao, Nan, et al. “Highly efficient induction and long-term maintenance of multipotent cardiovascular progenitors from human pluripotent stem cells under defined conditions.” Cell research 23.9 (2013): 1119-1132. [cited by applicant]
Foshay, Kara, et al. “JAK2/STAT3 directs cardiomyogenesis within murine embryonic stem cells in vitro.” Stem Cells 23.4 (2005): 530-543. [cited by applicant]
Qyang, Yibing, et al. “The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/?-catenin pathway.” Cell stem cell 1.2 (2007): 165-179. [cited by applicant]
Yu et al Science, 2009, 324, 797-801. [cited by applicant]
Kojima and Ieda, Cell. Mol. Life Sci. 2017, 1-13. [cited by applicant]
Ieda et al, Cell. 201 O Aug. 6; 142(3): 375-386. [cited by applicant]
Islas, Jose Francisco, et al. “Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors.” Proceedings of the National Academy of Sciences 109.32 (2012): 13016-13021. [cited by applicant]
Abu-Issa, Radwan, and Margaret L. Kirby. “Heart field: from mesoderm to heart tube.” Annu. Rev. Cell Dev. Biol. 23 (2007): 45-68. [cited by applicant]
Gossen, Manfred, and Hermann Bujard. “Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.” Proceedings of the National Academy of Sciences 89.12 (1992): 5547-5551. [cited by applicant]
Kattman, Steven J., et al. “Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines.” Cell stem cell 8.2 (2011 ): 228-240. [cited by applicant]
Kwon, Chulan, et al. “Canonical Wnt signaling is a positive regulator of mammalian cardiac progenitors.” Proceedings of the National Academy of Sciences 104.26 (2007): 10894-10899. [cited by applicant]
Lawson, Kristie A., et al. “Clonal analysis of epiblast fate during germ layer formation in the mouse embryo.” Development 113.3 (1991 ): 891-911. [cited by applicant]
Lu, Tung-Ying, et al. “Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells.” Nature communications 4 (2013). [cited by applicant]
Mader, Sylvie, and John H. White. “A steroid-inducible promoter for the controlled overexpression of cloned genes in eukaryotic cells.” Proceedings of the National Academy of Sciences 90.12 (1993): 5603-5607. [cited by applicant]
Madsen, Cort S., et al. “Smooth muscle-specific expression of the smooth muscle myosin heavy chain gene in transgenic mice requires 5′-flanking and first intronic DNA sequence.” Circulation Research 82.8 (1998): 908-917. [cited by applicant]
Miano, Joseph M., et al. “Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis.” Circulation research 75.5 (1994): 803-812. [cited by applicant]
Nelson, Daryl 0., et al. “Irx:4 identifies a chamber—specific cell population that contributes to ventricular myocardium development.” Developmental Dynamics 243.3 (2014): 381-392. [cited by applicant]
Scott, Ian C. “1 Life Before Nkx2. 5: Cardiovascular Progenitor Cells: Embryonic Origins and Development.” Current topics in developmental biology 100 (2012): 1. [abstract only]. [cited by applicant]
Snyder, Marylynn, et al. “Stat3 directly controls the expression of Tbx5, Nkx2. 5, and GATA4 and is essential for cardiomyocyte differentiation of P19CL6 cells.” Journal of Biological Chemistry 285.31 (2010): 23639-2364… [cited by applicant]
Tarui, Suguru, et al. “Direct Induction of Human Cardiac Progenitor Cells to Functional Cardiomyocytes by Defined Factors.” Circulation 124.21 Supplement (2011 ): A 11472. [abstract only]. [cited by applicant]
Wada, Rie, et al. “Induction of human cardiomyocyte-like cells from fibroblasts by defined factors.” Proceedings of the National Academy of Sciences 110.31 (2013): 12667-12672. [cited by applicant]
Wang, Yaolin et al. “A regulatory system for use in gene transfer.” Proceedings of the National Academy of Sciences 91.17 (1994): 8180-8184. [cited by applicant]
Zhang, Jianhua, et al. “Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells the matrix sandwich method.” Circulation research 111.9 (2012): 1125-1136. [cited by applicant]